voriconazole has been researched along with Cross Infection in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 11 (32.35) | 29.6817 |
| 2010's | 20 (58.82) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Colombo, AL; Costa, SF; da Matta, VL; de Souza Carvalho Melhem, M; dos Anjos Martins, M; Duboc de Almeida, GM; Levin, AS; Moretti, ML; Nucci, M; Rodero, L; Souza Dias, MB | 1 |
| Ahmad, S; Al-Sweih, N; Asadzadeh, M; Khan, Z | 1 |
| Ahmad, S; Al-Sweih, N; Alfouzan, W; Joseph, L; Khan, Z | 1 |
| Bénet, T; Bienvenu, AL; Cassier, P; Dananché, C; Dupont, D; Gustin, MP; Hénaff, L; Loeffert, ST; Vanhems, P; Wallon, M | 1 |
| Abd Al Aziz, S; Anani, M; Elkholy, A; Hassan, M; Hosny, M; Labib, D; Meshaal, MS; Rizk, H; Said, K | 1 |
| Chen, J; Huang, J; Li, L; Yang, Q | 1 |
| Goic-Barisic, I; Novak, A; Radic, M; Rubic, Z; Tomic, Z; Tonkic, M | 1 |
| Boucherit, K; Boucherit-Otmani, Z; Mazari, W | 1 |
| Kumar, A; Kumar, D; Singh, S; Tilak, R | 1 |
| Akan, H; Atilla, E | 1 |
| Carbajal, WH; Lozada, C; Reyes, HA; Valdez, LM | 1 |
| Chu, YZ; Fan, X; Kang, M; Kong, F; Kudinha, T; Li, RY; Liao, K; Lu, J; Ma, XJ; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Zhang, L; Zou, GL | 1 |
| Hollenbach, E | 1 |
| Fanci, R | 1 |
| Berger, N; Bonatti, H; Geltner, C; Grif, K; Lass-Flörl, C; Lechner, M; Margreiter, R; Stelzmueller, I | 1 |
| Adiri, Y; Karatela, S; Lyon, GM; Sunay, S | 1 |
| De Rosa, FG; Falcone, M; Ghezzi, MC; Pasero, D; Raponi, G; Russo, A; Toma, L; Venditti, M | 1 |
| Cormican, M; Hanahoe, B; Lyons, M; O'Connell, K | 1 |
| Caggiano, G; Cuna, T; Iatta, R; Montagna, MT | 1 |
| Mitrokhin, SD; Sokolov, AA | 1 |
| Bassetti, M; Molinari, MP; Mussap, M; Nicco, E; Taramasso, L; Viscoli, C | 1 |
| Andrés, R; Elías, T; Fernandez de Orueta, L; Pintado, V | 1 |
| Maack, KH; Tarp, B | 1 |
| Su, J; Sun, W; Xu, S; Yan, D | 1 |
| Chen, SC; Chu, YZ; Fan, H; Hu, TS; Hu, ZD; Kong, F; Liao, K; Lu, J; Ni, YX; Shao, HF; Sun, ZY; Wang, H; Xiao, M; Xu, YC; Yan, Y; Zou, GL | 1 |
| Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
| Bliss, JM; Gigliotti, F; Wellington, M | 1 |
| Bauer, M; Graninger, W; Joukhadar, C; Kulemann, V | 1 |
| Pemán, J; Zaragoza, R | 1 |
| Cornely, OA; Glöckner, A | 1 |
| Araujo, R; Pina-Vaz, C; Rodrigues, AG | 1 |
| Geiger, S; Herold, T; Nickenig, C; Ostermann, H; Rieger, C | 1 |
| Athan, E; Campbell, P; Chang, CC; Cheng, AC; Devitt, B; Hughes, AJ; Low, J; Styles, K | 1 |
| Patterson, TF | 1 |
6 review(s) available for voriconazole and Cross Infection
| Article | Year |
|---|---|
Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Deoxycholic Acid; Drug Combinations; Drug Therapy, Combination; Echinocandins; Fluconazole; Humans; Intensive Care Units; Itraconazole; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2008 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.
Topics: Anti-Bacterial Agents; Anticonvulsants; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Cross Infection; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Echinocandins; Food-Drug Interactions; Humans; Immunocompromised Host; Intensive Care Units; Lipopeptides; Liver; Mycoses; Peptides, Cyclic; Polypharmacy; Pyrimidines; Reverse Transcriptase Inhibitors; Triazoles; Voriconazole | 2005 |
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Critical Illness; Cross Infection; Deoxycholic Acid; Drug Combinations; Fluconazole; Humans; Intensive Care Units; Mycoses; Pyrimidines; Randomized Controlled Trials as Topic; Triazoles; Voriconazole | 2006 |
[Zygomycosis after hematogeneic stem cell transplantation--a current problem?].
Topics: Aspergillosis; Cancer Care Facilities; Cross Infection; Cross-Sectional Studies; Germany; Hematopoietic Stem Cell Transplantation; Humans; Long-Term Care; Opportunistic Infections; Pyrimidines; Risk Factors; Transplantation, Homologous; Triazoles; Voriconazole; Zygomycosis | 2006 |
Role of newer azoles in surgical patients.
Topics: Antifungal Agents; Azoles; Candidiasis; Cross Infection; Dose-Response Relationship, Drug; Drug Design; Fluconazole; Humans; Pyrimidines; Surgical Wound Infection; Triazoles; Voriconazole | 1999 |
1 trial(s) available for voriconazole and Cross Infection
| Article | Year |
|---|---|
[Modern antifungals in therapy of nosocomial mycosis in oncologic patients].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Cross Infection; Drug Resistance, Fungal; Female; Fluconazole; Humans; Male; Neoplasms; Pyrimidines; Triazoles; Voriconazole | 2011 |
27 other study(ies) available for voriconazole and Cross Infection
| Article | Year |
|---|---|
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Microbial Sensitivity Tests; Pichia | 2007 |
Molecular fingerprinting by multi-locus sequence typing identifies microevolution and nosocomial transmission of
Topics: Aged; Amphotericin B; Candida; Candida glabrata; Cross Infection; Fluconazole; Humans; Kuwait; Multilocus Sequence Typing; Phylogeny; Voriconazole | 2023 |
Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Topics: Antifungal Agents; Candida; Candidemia; Candidiasis; Cross Infection; Drug Resistance, Fungal; Fluconazole; Genes, Fungal; Humans; Kuwait; Micafungin; Microbial Sensitivity Tests; Pathology, Molecular; Voriconazole | 2020 |
Prospective survey of azole drug resistance among environmental and clinical isolates of Aspergillus fumigatus in a French University hospital during major demolition works.
Topics: Air Microbiology; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cross Infection; Drug Resistance, Fungal; Facility Design and Construction; France; Hospitals, University; Humans; Itraconazole; Voriconazole | 2018 |
Aspergillus endocarditis: Diagnostic criteria and predictors of outcome, A retrospective cohort study.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Cross Infection; Drug Therapy, Combination; Endocarditis; Endocarditis, Bacterial; Endocardium; Female; Heart Valve Prosthesis; Hospital Mortality; Humans; Incidence; Male; Middle Aged; Prognosis; Prosthesis-Related Infections; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Voriconazole | 2018 |
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
Topics: Adult; Antifungal Agents; Cross Infection; End Stage Liver Disease; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Rate; Triazoles; Voriconazole | 2013 |
Prompt diagnosis and effective treatment of Trichosporon asahii catheter-related infection in non-immunocompromised neurosurgical patient.
Topics: Aged; Antifungal Agents; Catheter-Related Infections; Coma; Cross Infection; Humans; Male; Microbial Sensitivity Tests; Neurosurgical Procedures; Treatment Outcome; Trichosporon; Trichosporonosis; Voriconazole | 2015 |
In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases.
Topics: Algeria; Amphotericin B; Antifungal Agents; Biofilms; Candida; Caspofungin; Cross Infection; Dental Clinics; Dental Facilities; Dental Service, Hospital; Echinocandins; Equipment Contamination; Hospitals, University; Humans; Lipopeptides; Microbial Sensitivity Tests; Voriconazole; Water Quality | 2015 |
Candidemia-induced pediatric sepsis and its association with free radicals, nitric oxide, and cytokine level in host.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida; Candidemia; Candidiasis; Child; Child, Preschool; Cross Infection; Cytokines; Female; Fluconazole; Free Radicals; Humans; Incidence; India; Infant; Infant, Newborn; Intensive Care Units; Interleukin-10; Interleukin-1beta; Male; Microbial Sensitivity Tests; Nitric Oxide; Nitric Oxide Synthase; Sepsis; Tumor Necrosis Factor-alpha; Voriconazole | 2015 |
Antifungal Treatment in Stem Cell Transplantation Centers in Turkey.
Topics: Adult; Allografts; Amphotericin B; Antifungal Agents; Child; Cross Infection; Diagnostic Tests, Routine; Drug Substitution; Drug Therapy, Combination; Drug Utilization; Febrile Neutropenia; Health Care Surveys; Health Facilities; Humans; Infection Control; Mycoses; Stem Cell Transplantation; Transplantation, Autologous; Turkey; Voriconazole | 2016 |
Successful medical treatment of infective endocarditis caused by Candida parapsilosis in an immunocompromised patient.
Topics: Adult; Anidulafungin; Antifungal Agents; Aorta; Candida; Candidiasis; Cross Infection; Echinocandins; Echocardiography; Endocarditis; Female; Humans; Immunocompromised Host; Ovarian Neoplasms; Voriconazole | 2015 |
Investigation of an unrecognized large-scale outbreak of Candida parapsilosis sensu stricto fungaemia in a tertiary-care hospital in China.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida parapsilosis; Candidemia; China; Cross Infection; Disease Outbreaks; Female; Fluconazole; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Mycological Typing Techniques; Phylogeny; Tertiary Care Centers; Voriconazole; Young Adult | 2016 |
Breakthrough Candida dubliniensis fungemia in an acute myeloid leukemia patient during voriconazole therapy successfully treated with caspofungin.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Caspofungin; Catheter-Related Infections; Cross Infection; Echinocandins; Fungemia; Humans; Leukemia, Myeloid, Acute; Lipopeptides; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2009 |
Infections caused by Candida krusei in five transplant and two surgical patients.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Caspofungin; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Fungal; Echinocandins; Female; Genotype; Humans; Immunocompromised Host; Lipopeptides; Male; Middle Aged; Mycological Typing Techniques; Organ Transplantation; Postoperative Complications; Pyrimidines; Random Amplified Polymorphic DNA Technique; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Antifungal susceptibility testing of Candida isolates from the Candida surveillance study.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Echinocandins; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2010 |
Clinical experience of anidulafungin for the treatment of patients with documented candidemia.
Topics: Anidulafungin; Antifungal Agents; Candida; Candidemia; Catheters, Indwelling; Cross Infection; Echinocandins; Female; Fluconazole; Humans; Italy; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2010 |
Antifungal susceptibility testing and candidaemia at a tertiary referral hospital.
Topics: Antifungal Agents; Candidemia; Cross Infection; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility testing of a 10-year collection of Candida spp. isolated from patients with candidemia.
Topics: Antifungal Agents; Candida; Candidemia; Cross Infection; Drug Resistance, Fungal; Fluconazole; Hospitals, University; Humans; Intensive Care Units; Italy; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2011 |
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy.
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Communicable Disease Control; Cross Infection; Echinocandins; Female; Fluconazole; Hospitals; Humans; Italy; Itraconazole; Lipopeptides; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Vertebral aspergillosis in a cirrhotic patient: an uncommon cause of spondylitis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Biomarkers; Cross Infection; Fatal Outcome; Galactose; Haemophilus influenzae; Hepatitis C, Chronic; Humans; Immunocompromised Host; Liver Cirrhosis; Low Back Pain; Lumbar Vertebrae; Male; Mannans; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Spondylitis; Triazoles; Voriconazole | 2012 |
[Fungal infection secondary to treatment of Escherichia coli in a critically ill patient].
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Aspergillus; Candida; Candidiasis; Caspofungin; Cross Infection; Drug Resistance, Bacterial; Drug Therapy, Combination; Echinocandins; Escherichia coli; Fungemia; Humans; Lipopeptides; Male; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2012 |
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Intergenic; Drug Resistance, Multiple, Fungal; Female; Flucytosine; Genetic Variation; Genotype; Hemolysin Proteins; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Urinary Tract Infections; Virulence Factors; Voriconazole | 2012 |
In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.
Topics: Antifungal Agents; China; Cross Infection; Drug Resistance, Fungal; Epidemiological Monitoring; Fluconazole; Humans; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Yeasts | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Susceptibility of environmental versus clinical strains of pathogenic Aspergillus.
Topics: Air Microbiology; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Cross Infection; Echinocandins; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole; Water Microbiology | 2007 |
Breakthrough infection of Trichosporon asahii during posaconazole treatment in a patient with acute myeloid leukaemia.
Topics: Aged; Amphotericin B; Antifungal Agents; Cross Infection; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Mycoses; Pyrimidines; Triazoles; Trichosporon; Voriconazole | 2007 |
Successful control of an outbreak of invasive aspergillosis in a regional haematology unit during hospital construction works.
Topics: Antifungal Agents; Aspergillosis; Chemoprevention; Cross Infection; Disease Outbreaks; Environmental Exposure; Hematology; Hospital Design and Construction; Hospital Units; Humans; Infection Control; Pyrimidines; Triazoles; Voriconazole | 2008 |